Early Treatment Intensification in T2DM, The Time is Now
29 Jun 2020
It is estimated 3.3 million Malaysians are diabetic, with another 1.7 million people living with undiagnosed diabetes
At the Novartis-sponsored VERIFY Soft Launch held at Le Meridien, Kuala Lumpur, two distinguished speakers spoke on the latest updates in glucose-lowering therapy and the benefit of early treatment intensification using combination therapy (ie, vildagliptin/metformin) in the management of T2DM.
Related MIMS Drugs